首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

PATHOLOGY & ONCOLOGY RESEARCH
ISSN：1219-4956

PATHOLOGY & ONCOLOGY RESEARCH

PATHOL ONCOL RES
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：偏慢,4-8周
新锐分区：医学4区
年发文量：65
影响因子：2.3
JCR分区：Q2

基本信息

病理学与肿瘤学研究（POR）是病理学与肿瘤学的交叉学科，包括临床前和转化研究、诊断和治疗。此外，POR是一个国际论坛，用于快速交流评论、原创研究、优秀和新奇的评论和专题报告。每季度出版一次，POR致力于让科学家了解选定生物医学领域的发展，弥合基础研究和临床医学之间差距。POR的一个特殊目标是促进中欧和东欧地区同事的病理学和肿瘤学出版活动。该杂志将感兴趣的病理学家，和广泛的实验和临床肿瘤学家，以及相关专家。POR得到了公认的国际咨询委员会和Arányi基金会的支持。
1219-4956SCIE/Scopus收录/DOAJ开放期刊
2.3
点击查看最新影响趋势>
2.6
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
PATHOLOGY 病理学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q3
208/328
学科：PATHOLOGY
SCIE
Q2
40/90
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q2
150/328
学科：PATHOLOGY
SCIE
Q3
47/90
44
65
点击查看年发文量趋势图>
25%容易偏慢,4-8周-医学-病理学
4.3%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
73.85%100%1.85%
CiteScore：4.60
SJR：0.714
SNIP：0.616
学科类别分区排名百分位
大类：Medicine
小类：Pathology and Forensic Medicine
Q2
56 / 204
大类：Medicine
小类：Oncology
Q2
179 / 415
大类：Medicine
小类：Cancer Research
Q3
136 / 233

期刊高被引文献

Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-018-00569-x
MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-018-0552-z
Histone Modifications and their Role in Colorectal Cancer (Review)
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00663-8
Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00685-2
Solid-pseudopapillary Neoplasms of the Pancreas is still an Enigma: a Clinicopathological Review
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00671-8
Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00580-w
Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00623-2
Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00626-z
Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00607-2
ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-κB Pathway
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00637-w
Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00641-0
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00677-2
Syndecan-1 in Liver Diseases
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00617-0
Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00659-4
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00620-5
Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00708-y
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00773-3
Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00756-4
Genetic Polymorphisms in the Vitamin D Pathway and Non-small Cell Lung Cancer Survival
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00702-4
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00734-w
KIT Mutation Incidence and Pattern of Melanoma in Central Europe
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00788-w
Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00760-8
All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00662-9
Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00705-1
BGP-15 Protects Mitochondria in Acute, Acetaminophen Overdose Induced Liver Injury
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00721-1
Immunohistochemical Characterization of Reactive Epithelial Changes in Odontogenic Keratocysts
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00749-3
Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00757-3
Adaptation of Fatigue Affected Changes in Muscle EMG Frequency Characteristics for the Determination of Training Load in Physical Therapy for Cancer Patients
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00668-3
Targeted Mutational Profiling and a Powerful Risk Score as Additional Tools for the Diagnosis of Papillary Thyroid Cancer
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00772-4
Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00678-1
Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00715-z
Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00604-5
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00652-x
The Impact of Beta-Catenin and glutathione-S-transferase Gene Polymorphisms on the Treatment Results and Survival of Multiple Myeloma Patients
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00747-5
Inhibitory Effect of (2R)-1-(1-Benzofuran-2-yl)-N-propylpentan-2-amine on Lung Adenocarcinoma
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00603-6
Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00726-w
Season Dependent Changes in the Expression of Protein Kinase C Isoenzymes in a Female Patient with Systemic Lupus Erythematosus
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00591-7
AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00696-z
Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00769-z
miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma
来源期刊：Pathology Oncology ResearchDOI：10.1007/s12253-019-00605-4

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
PATHOLOGY 病理学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
PATHOLOGY 病理学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
PATHOLOGY 病理学
4区
否
否